Remdesivir does not reduce mortality in ventilated patients with COVID-19
1. No significant decrease in mortality risk was seen in ventilated patients with COVID-19 on remdesivir compared to control. 2. ...
Tag: Coronavirus
Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males
1. The highest incidence of myocarditis or pericarditis was seen after the second dose of Moderna (mRNA-1273) in young men ...
Vaccination boosted immunity acquired from previous SARS-CoV-2 infection
1. Two doses of the Pfizer-BioNTech BNT162b2 vaccine were linked to high immediate protection again severe acute respiratory syndrome coronary ...
Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes
1. One dose of Ad26.COV2.S (Johnson & Johnson) provided some protection against moderate to severe Covid-19-related infection and medical intervention. ...
BNT162b2 safe and efficacious in children 5 to 11 years of age
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11 years of ...
Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection by more than 50%. 2. ...
Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to ...
Early ivermectin treatment does not lower Covid-19 related hospitalizations
1. Ivermectin treatment did not lower the incidence of medical admission to a hospital due to the progression of Covid-19. ...
Covid-19 vaccines and boosters are transiently effective against the Omicron
1. Two doses of BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccine provided good protection against the Omicron (B.1.1.529) variant but rapidly ...
Protection against SARS-CoV-2 highest after infection-acquired immunity boosted with vaccination in health care workers
1. SARS-CoV-2 infection-acquired immunity waned after 1 year, but immune protection remained high beyond 1 year in those boosted with ...